• Pfizer’s oral diabetes drug demonstrated promising weight loss that some experts say could work just as fast as Novo Nordisk’s highly sought after Ozempic.
• In the mid-stage trial, over 400 adults with Type 2 diabetes took Pfizer’s danuglipron twice a day or a placebo pill for roughly four months to test its efficacy.
• The results showed that every dose of the danuglipron pill reduced patients’ blood sugar at week 16 compared to the placebo.

Tagged: Health & Wellness